Evidence map›Paper›PMID 32892980›Full record

ArticleCirugia espanola2021

National survey on the treatment of cholelitiasis in Spain during the initial period of the COVID-19 pandemic.

Benedetto Ielpo, Mikel Prieto, Irene Ortega, José María Balibrea, Inés Rubio-Pérez, Montse Juvany, Miguel Ángel Gómez-Bravo, José Manuel Ramia

Open access · greenAbstract readMulticenter Study
In one paragraph

Article in Cirugia espanola, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.6field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 20 citations in OpenAlex.

  1. Review
  2. How did the general surgeons intend to treat acute calculous cholecystitis during COVID-19 era?Results of online survey.Ulusal travma ve acil cerrahi dergisi = Turkish journal of trauma & emergency surgery : TJTES · 2022
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 7 institutions in 1 country.

Benedetto IelpoUnidad de Cirugia Hepatobiliopancreática, Hospital Universitario del Mar, Barcelona, España. Electronic address: ielpo.b@gmail.com.
Mikel PrietoUnidad Hepatobiliar, Transplante Hepático y Retroperitoneo, Hospital Universitario Cruces, Bilbao, España.
Irene OrtegaSección de Cirugía Hepatobiliopancreática, Hospital Universitario Infanta Sofía, San Sebastián de los Reyes, Madrid. Universidad Europea de Madrid, Madrid, España.
José María BalibreaServicio de Cirugía Gastrointestinal (ICMDiM), Hospital Clínic de Barcelona, Universitat de Barcelona. Sección de Infección Quirúrgica, AEC, Barcelona, España.
Inés Rubio-PérezServicio de Cirugía General, Hospital Universitario La Paz, Madrid, España.
Montse JuvanyServicio de Cirugía General, Hospital General de Granollers, Universitat Internacional de Catalunya, Barcelona, España.
Miguel Ángel Gómez-BravoUnidad de Cirugía HPB y Trasplantes, Hospital Universitario Virgen del Rocío, Sevilla, España.
José Manuel RamiaServicio de Cirugía, Hospital Universitario de Guadalajara, Guadalajara, España.
Hospital Clínic de Barcelona · ESHospital de Cruces · ESHospital General de Granollers · ESHospital Universitario de Guadalajara · ESHospital Universitario Infanta Sofía · ESHospital Universitario La Paz · ESHospital Universitario Virgen del Rocío · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionThe extraordinary impact of COVID-19 pandemic on Spanish hospitals has led to a redistribution of resources for the treatment of these patients, with a decreased capacity of care for other common diseases. The aim of the present study is to analyse how this situation has affected the treatment of cholecystitis and cholelythiasis.

methodsIt is a descriptive national study after online voluntary distribution of a specific questionnaire with Google Drive™ to members of the Spanish Association of Surgeons (AEC).

resultsWe received 153 answers (one per hospital). Elective cholecystectomies have been cancelled in 96.7% of centres. Conservative treatment for acute cholecystitis has been selected in 90% (previously 18%), and if operated, 95% have been performed laparoscopically. Globally, only 49% perform preoperative diagnostic tests for SARS-CoV-2, and 58.5% recognize there have been cases confirmed postoperatively after other surgeries, with worse surgical outcomes in 54%.

conclusionsThis survey shows that most of the Spanish centers are following the surgical societies suggestions during the pandemic. However, some data requires to be taken into account for the next phase of the pandemic.

Indexed as

COVID-19Cholecystitis, AcuteCholelithiasisHealth Care SurveysHumansSpainAcute cholecystitisCholelithiasisColecistitis agudaColelitiasisCOVID-19EncuestaSARS-CoV-2Survey

Identifiers

PMID32892980
PMCPMC8088215
OpenAlexW3043586210

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.